Ranibizumab

Aflibercept in Recurrent or Persistent CNV

Effect of Levosulpiride on Retinal Alterations in Patients With Diabetic Retinopathy and Diabetic Macular Edema

Extension Study for the Port Delivery System With Ranibizumab (Portal)

A Feasibility Study Using CLINIMACS® for Alpha/Beta T-Cell Depletion in Stem Cell Transplant

Exclusive Human-milk in Preterm NEOnates and Early VASCular Aging Risk Factors (NEOVASC)

A Study Assessing Corneal Endothelial Cells in Participants With Neovascular Age-related Macular Degeneration (nAMD) Treated With the Port Delivery System With Ranibizumab (PDS)

Assess the Safety and Efficacy of Sovateltide in Patients With Acute Cerebral Ischemic Stroke

A Study of SNP-ACTH (1-39) Gel in Patients With Primary Membranous Nephropathy

Phase 1/2 Study of HYP-2090PTSA in Patients With Advanced Solid Tumors Harboring KRAS Mutation

Multicenter Real-life Observational Study Switched Aflibercept or Ranibizumab to Faricimab in Patients With AMD.

Telacebec (T) Treatment in Adults With Buruli Ulcer (BU). (TREAT BU)

Evolution of Functional Gastrointestinal Disorders in Infants Fed With a New Infant Formula

Phase 1/2 Clinical Study of HY07121 Powder for Solution for Infusion in Patients With Advanced Solid Tumors

Optimization of Surgical Hand Preparation Using Sorbectol

Evaluation of Efficacy of Anthelios Sunscreen on Face Versus Usual Routine on Signs of Aging

A Phase I/II Study of HYP-6589 Monotherapy in Treating Advanced Solid Tumors and in Combination With Tyrosine Kinase Inhibitors in Treating Patients With Advanced NSCLC Positive for Driver Genes

A Comparative Study of Cosmetic Product in Subjects With Facial Acne During an Associated-treatment Phase Followed by a Maintenance Phase

A Phase I Trial of 61Cu-NODAGA-PSMA for Patients with Prostate Cancer

Assessment of Quizartinib Pharmacokinetic in Subjects With Severe Hepatic Impairment

Evaluation of the Effects of Two Dietary Supplement Formulations on the Lipid Profile in Mild Hypercholesterolemia

A Study of 36-Week Refill Exchanges of Port Delivery System (PDS) With Ranibizumab in nAMD

Pharmacogenomics of antiVEGF in Patients With Age-Associated Macular Degeneration (AMD)

Effects of Lemborexant on Insomnia and Its Relationship to Mood and Behavior on Opioid Use Disorder Subjects

Anti-vascular Endothelial Growth Factor (Anti-VEGF) Monotherapy vs Anti-VEGF Followed by Subthreshold Micropulse Laser for Treating Severe Diabetic Macular Oedema When the Central Retina Goes <400 Microns

Clinical Trial for the Comparative Evaluation of Acid Suppression and Symptom Management of Gastroesophageal Reflux Disease With the Administration of Tegoprazan or Pantoprazole

Multiple Ascending Dose Study to Evaluate the Safety, Tolerability and Pharmacokinetics of KSHN001034 in Healthy Postmenopausal Female Volunteers

Study to Assess the Injection Burden, Adverse Events, Change in Disease Activity, and Long-Term Preservation of Visual Acuity of Surabgene Lomparvovec in Adult Participants With Neovascular Age-Related Macular Degeneration (nAMD)

Tolerance and Efficacy Open-label Study With RV4421B, in Various Populations With Atopic Dermatitis for 12 Weeks

A Phase I/Ⅱ Human Study of HY0001a for Injection in Adult Participants With Advanced Solid Tumors

Probiotic Impact on Cognitive Performance, and Metabolic Outcomes in Overweight Young Adults With Impaired Glucose Regulation

Rapid Response of Stem Cells and Immune Cells for Efficacy

Novel Skin Barrier Product Versus Petrolatum for Skin Barrier Dysfunction

Clinical Trial: Rapid Immune Modulating Effects

Clinical Trial on Rapid Immune Modulating Effects

Efficacy of EXPAREL vs. Bupivacaine

Identification of Molecular Signals in Vitreous Humor Associated With Suboptimal Response to Vascular Endothelial Growth Factor (VEGF) Inhibition in Neovascular Age-related Macular Degeneration (nAMD) Within a Clinical Trial Setting

Effects of Staged Adapted Inclusions in Infant Cereals on Oral-motors Patterns of 6-24 Month-old Children

Effect of Young Child Formula on Iron Status in Children 1-3 Years of Age.

Effects of the Consumption of Test Product on Urination in Healthy Japanese Adults

A Bioequivalence Study of PP3M in Patients With Schizophrenia

Effect of L. Reuteri LM1063 on Sleep Health Improvement

Efficacy Evaluation Study of BAT5906 and Lucentis® in Patients With Diabetic Macular Edema

Biomarkers in Diabetic Retinopathy Treated With Faricimab vs Biosimilar Ranibizumab

Effect of Lactiplantibacillus Plantarum LM1001 on Muscle Strength in Older Adults

Post-Extraction Healing: microRepair vs Chlorhexidine

Bioequivalence Study of Ferric Carboxymaltose Injection in Healthy Chinese Participants Under Fasting Conditions

Phase I Study of QLC5508 in Advanced Solid Tumors: C-QTc, Pharmacokinetics (PK) Comparisons and Drug-drug Interaction

A Study to Evaluate Ibuprofen (IBU) 62.5 mg and Acetaminophen (APAP) 125 mg/5 ml in an Oral Liquid Suspension Fixed-Dose Combination Product in Children Aged 6 to 11 Years

Bioavailability, Biopotency and Food Effect Study of SCD0503 Compared to Subcutaneous Regular Human Insulin

Oil Pulling Whitening Mouthwash

Dimotec (Diosmin) 1000 mg Film Coated Tablet Fed Study

Safety and Efficacy Evaluation of SMZ1 With Ranibizumab in Patients With Neovascular Age-related Macular Degeneration Without Polypoidal Choroidal Vasculopathy

Fermented Dairy Product and Bifidobacterium Diversity

Incidence of Hypoxia During Intravitreal Anti-VEGF (Vascular Endothelial Growth Factor) Injections for Retinopathy of Prematurity (ROP) Under Topical Anesthesia

Oil Pulling Reduction

Kimchi Powder on Gut Health

A Study in Healthy People to Test How Zongertinib is Taken up in the Body When Given as Tablets Made by Two Different Manufacturers With or Without Food

A Clinical Study to Evaluate the Efficacy and SPF of Two Test Materials According to an Adaptation of the Guidelines of the FDA Sunscreen Drug Products for Over-the-Counter Human Use

A Study of Ferric Derisomaltose Injection in Chinese Participants With Iron Deficiency Anemia Under Fasting Conditions

Intravitreal Injections of rhuFab V2 in Combination With Visudyne in Subjects With Age Related Macular Degeneration (AMD)

A Study to Evaluate rhuFab V2 in Subjects With Minimally Classic or Occult Subfoveal Neovascular Macular Degeneration

A Study to Compare rhuFab V2 With Verteporfin Photodynamic in Treating Subfoveal Neovascular Macular Degeneration

Ranibizumab Injections to Treat Retinal Tumors in Patients With Von Hippel-Lindau Syndrome

A Study of rhuFab V2 (Ranibizumab) in Subjects With Subfoveal Choroidal Neovascularization Secondary to Age-Related Macular Degeneration (AMD)

Extension Study of rhuFab V2 in Subjects With Neovascular Age-Related Macular Degeneration (AMD)

A Study to Evaluate Ranibizumab in Subjects With Choroidal Neovascularization (CNV) Secondary to Age-Related Macular Degeneration (AMD)

Efficacy and Safety of Ranibizumab in Patients With Subfoveal Choroidal Neovascularization (CNV) Secondary to Age-related Macular Degeneration (AMD)

Safety and Efficacy of Ranibizumab in Diabetic Macular Edema With Center Involvement

Safety and Efficacy of Ranibizumab in Japanese Patients With Subfoveal Choroidal Neovascularization Secondary to Age-related Macular Degeneration

Study of Ranibizumab Administered in Conjunction With Photodynamic Therapy With Verteporfin in Patients With Subfoveal Choroidal Neovascularization and Age-Related Macular Degeneration

Infliximab, Sirolimus and Daclizumab to Treat Age-Related Macular Degeneration

SUSTAIN - Study of Ranibizumab in Patients With Subfoveal Choroidal Neovascularization Secondary to Age-Related Macular Degeneration

Prospective OCT Study With Lucentis for Neovascular AMD (PrONTO Study)

Fluvoxamine Maleate in the Treatment of Obsessive-Compulsive Disorder: A Post-marketing Clinical Study in Children and Adolescents

Fluvoxamine Maleate in the Treatment of Depression/Depressive State : A Post-marketing Clinical Study in Children and Adolescents

Ranibizumab in Hemorrhagic Choroidal Neovascularization Trial

An OCT-Guided Variable Dosing Regimen With Ranibizumab for the Treatment of Neovascular AMD

Ranibizumab in Idiopathic Parafoveal Telangiectasia (RIPT) Trial

An Extension Study to Evaluate the Safety and Tolerability of Ranibizumab in Subjects With Choroidal Neovascularization Secondary to AMD or Macular Edema Secondary to RVO

Lucentis (Ranibizumab) for Eales' Disease

Efficacy Study of Lucentis in the Treatment of Diabetic Macular Edema

Triple Therapy - PDT Plus IVD and Intravitreal Ranibizumab Versus Lucentis Monotherapy to Treat Age-Related Macular Degeneration

A Study Using Intravitreal Injections of a Small Interfering RNA in Patients With Age-Related Macular Degeneration

Safety Study of Ranibizumab Eye Injections to Treat Choroidal Neovascularization That Was Caused Other Than by Age-Related Macular Degeneration.

Study To Determine Safety/Efficacy of Lucentis For Treatment Of Retinal Angiomatous Proliferation Secondary To Age Related Macular Degeneration

Intravitreal Ranibizumab Treatment of Central Retinal Vein Occlusion With Macular Edema

Imatinib Mesylate Combined With Intravitreal Ranibizumab in the Treatment of Choroidal Neovascularization Secondary to Age-Related Macular Degeneration

Intravitreal Ranibizumab Treatment of Central Serous Chorioretinopathy

Rubeosis Anti-VEGF (RAVE) Trial for Ischemic Central Retinal Vein Occlusion

Lucentis for Central Retinal Vein Occlusion (CRVO)

Ranibizumab (Lucentis) for Macular Edema Secondary to Vein Occlusions

The Ranibizumab for Edema of the mAcula in Diabetes-2 (READ-2) Study

Immediate Effects of Lucentis® in Conjunction With Photodynamic Therapy With Visudyne® in Exudative AMD(IECOMB)

Intraocular Pressure Immediately Following Intravitreous Injection of Ranibizumab

Lucentis Utilizing Visudyne (LUV Trial) Combination Therapy in the Treatment of Age-Related Macular Degeneration

Ranibizumab for Polypoidal Choroidal Vasculopathy (PCV)

Study Comparing Ranibizumab Monotherapy With Combined Verteporfin Therapy in Subfoveal CNV

Verteporfin Photodynamic Therapy Administered in Conjunction With Ranibizumab in Patients With Subfoveal Choroidal Neovascularization Secondary to Age-related Macular Degeneration (AMD)

Efficacy/Safety of Verteporfin Photodynamic Therapy and Ranibizumab Compared With Ranibizumab in Patients With Subfoveal Choroidal Neovascularization

Study Comparing 0.5mg of Ranibizumab and Higher Doses in the Treatment of Clinically Significant Diabetic Macular Edema

Laser-Ranibizumab-Triamcinolone for Diabetic Macular Edema

Laser-Ranibizumab-Triamcinolone for Proliferative Diabetic Retinopathy

A Study of Strontium90 Beta Radiation With Lucentis to Treat Age-Related Macular Degeneration

Study of Treatment Effects of Combination Therapy of Lucentis Plus Reduced Fluence PDT With Visudyne in Patients With Exudative AMD

Effect of Ranibizumab on Malignant Conjunctival Neoplasia

Injected Ranibizumab to Treat Macular Telangiectasia With New Blood Vessel Formation

Injected Ranibizumab to Treat Macular Telangiectasia Without New Blood Vessel Formation

Second Line Therapy to Treat Age-related Macular Degeneration (AMD) for Patients Not Responding Well to Lucentis Therapy by Itself

Lucentis for Treatment of Macular Edema

Scotoma Reduction in AMD Patients Treated With Ranibizumab

A Study of Genetic and Environmental Factors and Their Effect on Response to Treatment With Lucentis (Ranibizumab) for Wet AMD

EXTEND III - Efficacy and Safety of Ranibizumab in Patients With Subfoveal Choroidal Neovascularization (CNV) Secondary to Age-related Macular Degeneration (AMD)

Treatment of Exudative and Vasogenic Chorioretinal Diseases Including Variants of AMD and Other CNV Related Maculopathy

A Study of Ranibizumab Injection in Subjects With Clinically Significant Macular Edema (ME) With Center Involvement Secondary to Diabetes Mellitus (RISE)

A Study of Ranibizumab Injection in Subjects With Clinically Significant Macular Edema (ME) With Center Involvement Secondary to Diabetes Mellitus (RIDE)

Reduced Fluence Photodynamic Therapy (PDT) With Visudyne in Combination With Lucentis for Age-Related Macular Degeneration

Study Evaluating Genotypes Using Lucentis

Bioequivalence Study of Generic GPO Ritonavir Versus Norvir®

A Study of the Efficacy and Safety of Ranibizumab Injection in Patients With Macular Edema Secondary to Central Retinal Vein Occlusion (CRUISE)

A Study of the Efficacy and Safety of Ranibizumab Injection in Patients With Macular Edema Secondary to Branch Retinal Vein Occlusion (BRAVO)

Reduced Fluence Visudyne-Anti-VEGF-Dexamethasone In Combination for AMD Lesions (RADICAL)

Lucentis for Inflammatory Macular Edema Trial

Safety & Efficacy Study Evaluating the Combination of Bevasiranib & Lucentis Therapy in Wet AMD

CAPTAIN:Choroidal Neovascularization Assessment by Pattern Electroretinography

Ranibizumab to Treat Type 2 Idiopathic Macular Telangiectasia (RAMA-Trial)

Safety and Tolerability of Ranibizumab in Patients With Subfoveal Choroidal Neovascularization Secondary to Age-related Macular Degeneration

Vascular Endothelial Growth Factor VEGF Trap-Eye:Investigation of Efficacy and Safety in Wet Age-Related Macular Degeneration(AMD)

Ranibizumab to Treat Choroidal Neovascularization (CNV) in Patients With Pseudoxanthoma Elasticum (PXE)

Safety and Efficacy of a New Treatment as Adjunctive Therapy to Anti-vascular Endothelial Growth Factor (Anti-VEGF) Treatment in Patients With Age-Related Macular Degeneration (AMD)

Evaluation of Ranibizumab in Proliferative Diabetic Retinopathy (PDR) Requiring Vitrectomy

Pilot Study of Lucentis Combined With Proton Beam Irradiation in Treating Wet Age-related Macular Degeneration

Ranibizumab and Reduced Fluence PDT for AMD

Evaluation of Dosing Interval of Higher Doses of Ranibizumab

Subretinal Lucentis for Hemorrhagic Age-related Macular Degeneration (AMD)

Changes in Retinal Function After Intravitreal Ranibizumab for Age-related Macular Degeneration

Intravitreal Ranibizumab for the Prevention of Radiation Maculopathy Following Plaque Radiotherapy

Bevacizumab Versus Ranibizumab for Diabetic Retinopathy

Ranibizumab Versus PDT for Presumed Ocular Histoplasmosis

Safety & Efficacy Study Evaluating the Combination of Bevasiranib & Lucentis Therapy in Wet AMD (CARBON)

Prevention of Vision Loss in Patients With Age-Related Macular Degeneration (AMD) by Intravitreal Injection of Bevacizumab and Ranibizumab

Ranibizumab Therapy for Non-arteritic Ischemic Optic Neuropathy

A Randomized Study Comparing Ranibizumab to Sham in Patients With Macular Edema Secondary to CRVO

A Phase 1, Safety, Tolerability and Pharmacokinetic Profile of Intravitreous Injections of E10030 (Anti-PDGF Pegylated Aptamer) in Subjects With Neovascular Age-Related Macular Degeneration

Photodynamic and Pharmacologic Treatment of CNV

Treatment of Failing Blebs With Ranibizumab

Efficacy and Safety Study of Lucentis (Ranibizumab) and Visudyne (Verteporfin) Combination Therapy in Neovascular AMD

Lucentis for Age-related Macular Degeneration Pigment Epithelial Detachments

Comparison of Age-related Macular Degeneration Treatments Trials: Lucentis-Avastin Trial

The Ranibizumab Plus Transpupillary Thermotherapy for Neovascular Age-Related Macular Degeneration (AMD) Study

Comparison of PEG Solutions With and Without Electrolytes in the Treatment of Constipation

The MAP Study: Fluocinolone Acetonide (FA)/Medidur (TM) for Age Related Macular Degeneration (AMD) Pilot

Detection of Neutralizing Antibodies in Patients Treated With Bevacizumab or Ranibizumab

Ranibizumab for Treatment of Persistent Diabetic Neovascularization Assessed by Wide-Field Imaging

Safety and Efficacy of ATG003 in Patients With AMD Receiving Anti-VEGF

Ranibizumab for Neovascularization in Sickle Cell Retinopathy

Lucentis Versus Mitomycin C During Glaucoma Surgery

Preoperative Skin Preparation Evaluation

Vascular Endothelial Growth Factor (VEGF) Trap-Eye: Investigation of Efficacy and Safety in Wet Age-Related Macular Degeneration (AMD)

The Effects of Bevacizumab and Ranibizumab on Ocular Pulse Amplitude in Neovascular Age Related Macular Degeneration (AMD)

Ranibizumab in Preventing Failure of Ahmed Valve Glaucoma Surgery

Bioavailability Study of Doxycycline Monohydrate Capsules and Monodox Under Fasting and Fed Conditions

Bioequivalence Study of Cabergoline Tablets and Dostinex Under Fed Conditions

Bioequivalence Study of Cabergoline Tablets and Dostinex Under Fasting Conditions

High Speed Indocyanine Green Angiography Findings in Ranibizumab Treatment for Wet Age-related Macular Degeneration

Ranibizumab for Neurofibromas Associated With Neurofibromatosis 1

Use of Ranibizumab With Mitomycin C During Trabeculectomy

Combined Pulsed Dye Laser and Topical Ranibizumab for Treatment of Port Wine Stain Birthmarks

Intravitreal Ranibizumab to Treat Macular Edema After Panretinal Photocoagulation (Phase II)

Efficacy and Safety of Verteporfin Added to Ranibizumab in the Treatment of Symptomatic Macular Polypoidal Choroidal Vasculopathy

Combined aPproach to Treatment Using Ranibizumab and Efalizumab for Diabetic Macular Edema Study: The CAPTURE DME Study

A Study to Evaluate the Neovista Ophthalmic System for the Treatment of Subfoveal CNV in Patients With AMD That Have Failed Primary Anti-VEGF Therapy

Lactacyd Radiance (Lactic Acid) Prophetic Patch Test

Lucentis as an Adjuvant Therapy With TTT-ICG Based in Choroidal Melanoma

Combination Lucentis and Ocular Photodynamic Therapy With Visudyne, With Evaluation-based Retreatment

Effectiveness and Safety of Topical Ranibizumab for Treatment of Corneal Neovascularization (NV)

Intraocular Anti-VEGF Compared With Intraocular Triamcinolone in Patients With Diabetic Macular Edema

Ranibizumab Injections to Treat Macular Telangiectasia With New Blood Vessel Growth

Ranibizumab Injections to Treat Macular Telangiectasia Without New Blood Vessel Growth

ARC1905 (Anti-C5 Aptamer) Given With Lucentis 0.5 mg In People With Neovascular Age-Related Macular Degeneration

The Effect of a Single Intravitreal Anti-VEGF Therapy on Optic Nerve Head Perfusion

Manta Study: Avastin Versus Lucentis in Age Related Macular Degeneration

Phase II Open Label Multicenter Study For Age Related Macular Degeneration Comparing PF-04523655 Versus Lucentis In The Treatment Of Subjects With CNV (MONET Study).

Effect of the Level of Dietary Protein on Infant Growth

Study of Efalizumab Combined With Intravitreal Ranibizumab in the Treatment of Age-Related Macular Degeneration

Pilot Study Reduced Fluence PDT /Visudyne With Ranibizumab vs Ranibizumab Monotherapy for Exudative Age-related Macular Degeneration (AMD)

Lucentis for New Onset Neovascular Glaucoma

VEGF-antagonism and Endothelial Function in Age-related Macular Degeneration (AMD)

Efficacy and Safety of Lisdexamfetamine Dimesylate (LDX) in Adolescents With Attention-Deficit/Hyperactivity Disorder (ADHD)

Ranibizumab for Treating Submacular Vascularized Pigment Epithelial Detachments

Effect of Intravitreal Ranibizumab on Radiation Retinopathy Following Plaque Brachytherapy for Choroidal Melanoma

Randomized Controlled Trial Comparing Efficacy and Tolerance of Four Pediculicides

Comparison of One Morphine Sulfate Sustained-Release 200mg Capsule With Two 100 mg KADIAN Capsules Under Fed Conditions

Comparison of One Morphine Sulfate Sustained-Release 200mg Capsule With Two 100 mg KADIAN Capsules Under Fasting Conditions

Comparison of Two KADIAN 10 mg Capsules to a KADIAN 20 mg Capsule Under Fasted Conditions

Comparison of Two KADIAN 10 mg Capsules to a KADIAN 20 mg Capsule Under Fed Conditions

Comparison of One Morphine Sulfate Sustained-Release 200 mg Capsule With Two 100 mg KADIAN Capsules on Applesauce

Study Investigating OCT, Multifocal ERG, and Microperimetry in Monthly Versus PRN Ranibizumab in Neovascular Age-Related Macular Degeneration

A Randomised Cross-over Study With Two 1-piece Urostomy Bags.

Ranibizumab in Combination With Proton Beam Irradiation for Choroidal Melanoma

Phase 2 Study of an Ocular Sirolimus (Rapamycin) Formulation in Combination With Lucentis® in Patients With Age-Related Macular Degeneration

Ranibizumab for the Inhibition of Neovascularization in Pterygia

Ranibizumab for the Inhibition of Neovascularization in the Cornea Following Corneal Transplant Surgery

Safety and Efficacy of a New Therapy as Adjunctive Therapy to Anti-vascular Endothelial Growth Factor (Anti-VEGF) in Subjects With Wet Age-Related Macular Degeneration (AMD)

Comparative Study to Evaluate KADIAN and Avinza in Healthy Adults

ERG/EOG Study in AMD Patients Treated With Ranibizumab

A Prospective Study Comparing Ranibizumab Plus Dexamethasone Combination Therapy Versus Ranibizumab Monotherapy for Wet AMD

Safety and Equivalence of a Generic Ciclopirox Olamine Cream Compared to the Reference Ciclopirox Cream 0.77% for the Treatment of Tinea Pedis

Bioequivalence Study Between Two Oral Formulations of Famotidine Tablets Under Fasting Conditions

Randomized Study to Compare the Bioavailability of Two Halobetasol Propionate 0.05% Topical Ointments

Randomized Study to Compare the Bioavailability of Three Halobetasol Propionate 0.05% Topical Creams

Randomized Study to Compare the Bioavailability of Two Fluticasone Propionate 0.005% Topical Ointments

Randomized Study to Compare the Bioavailability of Two Clobetasol Propionate 0.05% Topical Foams

Randomized Study to Compare the Bioequivalence of Two Fluticasone Propionate 0.05% Topical Creams

Safety and Equivalence of a Terconazole Vaginal Suppository (Test Product) Compared to the Reference Terconazole Vaginal Suppository in the Treatment of Vulvovaginal Candidiasis

Bioequivalence Study Between Two Oral Formulations of Naproxen 500 mg Tablets Under Fed Conditions

Bioequivalence Study Between Two Oral Formulations of Ibuprofen 800 mg Tablets Under Fed Conditions

Safety and Equivalence of a Generic Ciclopirox Olamine Topical Suspension Compared to the Reference Ciclopirox Topical Suspension 0.77% for the Treatment of Tinea Pedis

Bioequivalence Study Between Two Oral Formulations of Naproxen 500 mg Tablets Under Fasting Conditions

Bioequivalence Study Between Two Oral Formulations of Ibuprofen 800 mg Tablets Under Fasting Conditions

Investigates Improvement in Vision Following Switching From Avastin and Macugen Over to Lucentis

Randomized Study to Compare the Bioavailability of Three Mometasone Furoate 0.1% Topical Lotions

Combination Ranibizumab and Bromfenac for Neovascular Age-related Macular Degeneration

A Study of the NeoVista Ophthalmic System for the Treatment of Subfoveal CNV Associated With Wet AMD in Patients That Require Persistent Anti-VEGF Therapy

Treatment Of Radiation Retinopathy Trial

Efficacy of Ranibizumab in Combination With Photodynamic Therapy for Wet Age-Related Macular Degeneration

Ranibizumab and Peripheral Scatter Laser in Patients With Diabetic Macular Edema and Peripheral Nonperfusion

Evaluation of Safety and Efficacy of Once Monthly Ranibizumab Injections in Chinese Patients With Wet Age Related Macular Degeneration (AMD) Patients

Pilot Study of Ranibizumab (Lucentis) for Uveitic Cystoid Macular Edema

Dexmethylphenidate Hydrochloride Tablets Under Non-Fasting Conditions

Posterior Vitreous Detachment (PVD) Assessment During Dual Retinal Vein Occlusion (RVO) Lucentis Evaluations

Pravastatin Sodium 40 mg Tablets Food Challenge Study

Alendronate Sodium 70 mg Tablet Versus Fosamax® Under Fasting Conditions.

Ranibizumab (Lucentis) for Polypoidal Choroidal Vasculopathy

Ranibizumab Supplementing Panretinal Photocoagulation as Treatment for Iris/Angle Neovascularization in Retinal Ischemic Disease

Lucentis to Treat Pigment Epithelial Detachment

Study of Uveitic Macular Edema Treated With Ranibizumab or Steroids

The Efficacy of Oral Everolimus in Patients With Neovascular Age-related Macular Degeneration

Study to Assess on a Molecular Level the Influence of a 5 % Dexpanthenol Ointment in Subjects With Superficial Injuries

Pilot Study of Safety, Tolerability, Pharmacokinetics/Pharmacodynamics of RP103 Compared to Cystagon® in Patients With Cystinosis

Microperimetry and Optical Coherence Tomography (OCT) With Lucentis for Diabetic Macular Edema (DME)

Safety and Efficacy of AEG33773 Versus Placebo in Patients With Painful Diabetic Peripheral Neuropathy

A Study of Ranibizumab Administered Monthly or on an As-needed Basis in Patients With Subfoveal Neovascular Age-related Macular Degeneration (HARBOR)

Trabeculectomy With Mitomycin C Associated With Sub-conjunctival Injection of Ranibizumab

Lucentis in Advanced Macular Degeneration

Efficacy and Safety of Ranibizumab (Intravitreal Injections) Versus Laser Treatment in Patients With Visual Impairment Due to Diabetic Macular Edema

A Study of Tobramycin Inhalation Powder From a Modified Manufacturing Process Versus Placebo

Comparative Study With Photodynamic Therapy And Triamcinolone Versus Photodynamic Therapy, Triamcinolone And Ranibizumab In Patients With Subfoveal Choroidal Neovascularization

Safety and Efficacy of Intravitreal Ranibizumab as a Preoperative Adjunct Treatment Before Vitrectomy Surgery in Proliferative Diabetic Retinopathy (PDR) Compared to Vitrectomy Alone

Retinal and Retinal Pigment Epithelium (RPE) Autoimmunity in Age-related Macular Degeneration (AMD)

Antibacterial Treatment Against Diarrhea in Oral Rehydration Solution

Effect of Intravitreal Ranibizumab Injection With Retinal Vein Occlusion (RVO)

Intravitreal Ranibizumab for the Treatment of Choroidal Neovascularization in Ocular Histoplasmosis Syndrome

Combination of Ranibizumab and Verteporfin Therapy in Neovascular Age-related Macular Degeneration

Evaluation of the Effectiveness of an Alcohol Based Hand Gel for the Reduction of Warts on the Hands

Bioequivalence Study Comparing Two Test Products With One Reference Product, All Containing 5 mg Yohimbine

Intravitreal Ranibizumab in Retinal Pigment Epithelial Detachments

A Comparative Study Between Two Formulations of the Ciprofloxacin Hydrochloride + Hydrocortisone Otic Suspension

Effect of Probiotic Fermented Dairy Drinks on Intestinal Immune Response

Efficacy and Safety of Ranibizumab (Intravitreal Injections) in Patients With Visual Impairment Due to Diabetic Macular Edema

Comparative Bioavailability of Myfenax® and CellCept® in Kidney Transplant Patients

Impact of Formulation on Ciprofloxacin Oral Absorption

WALTZ - Wet Age-Related Macular Degeneration (AMD) AL-39324 Treatment Examination

Intravitreal Ranibizumab For Persistent New Vessels In Diabetic Retinopathy(Inipe Study)

Comparison of Intravitreal Ranibizumab and Macular Grid-pattern Laser for Treatment of Diabetic Macular Edema

Intravitreal Ranibizumab for Vitreous Hemorrhage Due to Proliferative Diabetic Retinopathy (N)

Ranibizumab DosE Comparison and the Role of LAser in REtinal Vein Occlusions

In Situ Caries Model of Fluoride Toothpastes

Macular EpiRetinal Brachytherapy Versus Lucentis® Only Treatment (MERLOT)

Effects of a Synbiotics-containing Starter Formula on Infant Growth

Class 3 Biowaivers

Impact of Lucentis on Psychological Morbidity in Patients With Retinal Vein Occlusion

Bevacizumab Versus Ranibizumab in Age Related Macular Degeneration

Ranibizumab Therapy for Choroidal Neovascularization (CNV) Asociated With Angioid Streaks

Study of 0444 Gel in the Treatment of Inflammatory Lesions of Rosacea

INTREPID - IRay Plus Anti-VEGF Treatment For Patients With Wet AMD

Use of Spectral OCT in Combination Therapy

A Study of Intravitreal Injections of 2.0mg Ranibizumab in Subjects With Chronic Fluid On OCT Post Multiple Injections With Ranibizumab (Super-dose Anti-VEgf SAVE Trial)

Ranibizumab in Patients With Branch Retinal Vein Occlusion

Lucentis for Macular Edema Associated With Central Retinal Vein Occlusion

Preoperative Intravitreal Ranibizumab for Persistent Diabetic Vitreous Haemorrhage:

Digestive Tolerance of Slightly Hydrolyzed Starter Infant Formula With Probiotics

Ranibizumab for the Treatment of Choroidal Neovascularisation (CNV) Secondary to Pathological Myopia (PM): an Individualized Regimen

A Randomized Study Evaluating the Therapeutic Equivalence of Two Butoconazole Nitrate Vaginal Cream, 2% Formulations

Clinical Study Between Two 1% Clindamycin/5% Benzoyl Peroxide Topical Gel Formulations

Lansoprazole 30 mg DR Capsule Fasting Study

Lansoprazole 30 mg DR Capsule Replicate Food Study

Lansoprazole 30 mg DR Capsule Fasting Replicate Sprinkle Study

Bladder Scan of Residual Urine With New Catheter

Study of 0416 Ointment in the Treatment of Atopic Dermatitis

Use of Ranibizumab to Treat Rubeosis in Diabetics Prior to Cataract Surgery

Ranibizumab for Edema of the Macula in Diabetes: Protocol 3 With High Dose - the READ 3 Study

Bioequivalence Study of Mycophenolate Mofetil 250 mg Capsule Under Fed Condition

Bioequivalence Study of Mycophenolate Mofetil 250 mg Capsule Under Fasting Condition

Bioequivalence Study of Tacrolimus 1 mg Capsule Under Fasting Condition

Bioequivalence Study of Tacrolimus 1 mg Capsule Under Fed Condition

Bioequivalence Study of Tacrolimus 5 mg Capsule Under Fasting Condition

Bioequivalence Study of Tacrolimus 5 mg Capsule Under Fed Condition

Bioequivalence Study of Cyclosporine 100mg Capsule Under Fasting Condition

Bioequivalence Study of Cyclosporine 100mg Capsule Under Fed Condition

Dose-optimization in Adolescents Aged 13-17 Diagnosed With Attention-deficit/Hyperactivity Disorder (ADHD) Using Extended-release Guanfacine HCl

Maintenance of Efficacy of Extended-Release Guanfacine HCl in Children and Adolescents With Attention-deficit/Hyperactivity Disorder (ADHD)

A Safety and Efficacy Study of E10030 (Anti-PDGF Pegylated Aptamer) Plus Lucentis for Neovascular Age-Related Macular Degeneration

Panretinal Photocoagulation (PRP) Plus Ranibizumab for Proliferative Diabetic Retinopathy

Evaluation of Dose-effect of a New Fermented Food in Healthy Adults

MIcrodoses of raNIbizumab in Diabetic MAcular Edema (MINIMA-2)

A Pilot Study to Evaluate the Role of High-dose Ranibizumab (2.0mg) in the Management of AMD in Patients With Persistent/Recurrent Macular Fluid Less Than 30 Days Following Treatment With Intravitreal Anti-VEGF Therapy (the LAST Study)

A Study to Assess the Role of a Gluten Free-dairy Free (GFCF) Diet in the Dietary Management of Autism Associated Gastrointestinal Disorders

A Study to Compare the Bioavailability of 300 mg Trazodone Hydrochloride Extended-release Caplets and 100 mg Trazodone Hydrochloride Immediate-release Tablets (Administered Three Times Daily)

Comparative Bioavailability Study of Two Prototypes of Trazodone Controlled-release Products and Two Marketed Reference Products in Healthy Volunteers

Safety and Efficacy of Dexamethasone as Adjunctive Therapy to Ranibizumab in Subjects With Choroidal Neovascularization and Age-Related Macular Degeneration

Efficacy and Safety of Lucentis for Clinically Significant Macular Edema Secondary to Central Retinal Vein Occlusion

Losartan 100 mg Tablets in Healthy Subjects Under Fasting Conditions

Losartan 100 mg Tablet in Healthy Subjects Under Non-Fasting Conditions

LUCAS (Lucentis Compared to Avastin Study)

Safety and Efficacy of Ranibizumab in Diabetic Macular Edema

Dose Ranging Study of Pazopanib to Treat Neovascular Age-Related Macular Degeneration

Safety, Efficacy and Cost-efficacy of Ranibizumab (Monotherapy or Combination With Laser) in the Treatment of Diabetic Macular Edema (DME)

Intravitreal Adalimumab in Patients With Choroidal Neovascularization Secondary to Age-related Macular Degeneration

Clinical Study Between Two Clindamycin 1%/Benzoyl Peroxide 5% Topical Gels

Study of 0417 Ointment in the Treatment of Atopic Dermatitis

Infant Formula Supplemented With a Special Fat Formulation for Premature Infants Following Discharge From Hospital

Comparison of Safety, Effectiveness and Quality of Life Outcomes Between Labeled Versus "Treat and Extend" Regimen in Turkish Patients With Choroidal Neovascularisation Due to Age-related Macular Degeneration (AMD)

Losartan Potassium/Hydrochlorothiazide 100/25 mg Tablets in Healthy Subjects Under Non-Fasting Conditions

Evaluation of AL-78898A in Exudative Age-Related Macular Degeneration

Buprenorphine 8 mg Sublingual Tablets Under Fasting Conditions

Estradiol/Norethindrone Acetate Tablets, 1/0.5 mg Under Fasting Conditions

Comparison of Ranibizumab Monotherapy and Ranibizumab Combination Therapies in Recurrent or Persistent Choroidal Neovascularization Secondary to Age-related Macular Degeneration

Efficacy and Safety of Sub-tenon Ranibizumab for Recurrent Pterygia

French Evaluation Group Avastin Versus Lucentis

Efficacy and Safety of Ranibizumab in Two "Treat and Extend" Treatment Algorithms Versus Ranibizumab As Needed in Patients With Macular Edema and Visual Impairment Secondary to Diabetes Mellitus

20089 TA+Lucentis Combo Intravitreal Injections for Treatment of Neovascular Age-related Macular Degeneration (AMD)

Estradiol/Norethindrone Acetate Tablets, 1/0.5 mg Under Fed Conditions

Anastrozole 1 mg Tablets Under Fasting Conditions

Drospirenone/Ethinyl Estradiol (3 mg/0.02 mg) Tablets Under Fasting Conditions.

Drospirenone/Ethinyl Estradiol (3 mg/0.02 mg) Tablets Under Non-Fasting Conditions

Bioequivalence of Adapalene Topical Gel in Patients With Acne Vulgaris

Anastrozole 1 mg Tablets Under Fed Conditions

Preliminary Safety and Efficacy of the PDS-1.0 in Patients With Neovascular Age Related Macular Degeneration (AMD)

HiPED - High Dose Lucentis for Persistent Pigment Epithelial Detachments in Age-related Macular Degeneration

Comparison of Intravitreal Ranibizumab and Macular Laser Photocoagulation for ME Following Branch Retinal Vein Occlusion (BRVO)

Anterior and Posterior Segment Vascular Changes Following Laser and Anti-Vascular Endothelial Growth Factor (VEGF) Treatment of Diabetic Retinopathy

Extended Follow-up of Patients With Macular Edema Due to Retinal Vein Occlusion

Ranibizumab for Diabetic Traction Retinal Detachment

High-Dose Lucentis (Ranibizumab 2.0mg) for the Treatment of Nonproliferative Idiopathic Parafoveal Telangiectasia

ProspectiveTrial of Proton Beam Combined With Anti-VEGF Therapy for Exudative Age-related Macular Degeneration (AMD)

Genetics in Non-response to Anti-VEGF Treatment in Exudative AMD

Safety & Tolerability of the IRay System in Subjects With Exudative Choroidal Neovascularization (CNV) Secondary to Age-Related Macular Degeneration (AMD)

Efficacy and Safety of Ranibizumab in Patients With Visual Impairment Due to Choroidal Neovascularization Secondary to Pathologic Myopia

Lucentis (Ranibizumab) in Diabetic Macular Oedema: a Treatment Evaluation

Study of 2.0 mg Ranibizumab in Subjects With Ischemic Central Retinal Vein Occlusion (RAVE2)

Effectiveness of Pancreatic Enzymes in Patients Pancreatic Insufficient: Comparison of Two Drugs

Vascular Endothelial Growth Factor (VEGF) & LOC387715/HTRA1 Polymorphism in Polypoidal Choroidal Vasculopathy

Safety and Pharmacokinetic Study of a Recombinant Coagulation Factor IX Albumin Fusion Protein in Subjects With Hemophilia B

Treatment of Epiretinal Membranes With Ranibizumab

OZURDEX in Age Related Macular Degeneration as Adjunct to Ranibizumab

Ranibizumab for Myopic Neovascularization

REtinal Vein OccLUsion Treatment With Scatter Laser Guided by UWFA in combiNAtion With Ranibizumab Study

90 mg Fluoxetine Hydrochloride Capsules Under Fasting Conditions

90 mg Fluoxetine Hydrochloride Capsules Under Non-Fasting Conditions

Safety Study of High-Dose Ranibizumab for Polypoidal Choroidal Vasculopathy

Sub-tenon Triamcinolone Acetonide in Age-Related Macular Degeneration as Adjunct to Ranibizumab

Ranibizumab as Adjuvant Therapy for the Treatment of Choroidal Melanoma (Cohort 2)

Ranibizumab as a Rescue Therapy for Diabetic Macular Edema

Serial Retinal Thickness Changes And Scotoma Size Measured With Lucentis Therapy

Evaluation of the Effect of Vitreous Composition Determined by Ultrasound and Optical Coherence Tomography (OCT) on Ranibizumab Therapy

Seven Year Update of Macular Degeneration Patients

Ranibizumab Treatment of Diabetic Macular Oedema With Bimonthly Monitoring After a Phase of Initial Treatment

Bioequivalence Study Comparing Clindamycin Phosphate (1.2%) and Tretinoin (0.025%) Topical Gel to Ziana and Placebo

Venlafaxine Hydrochloride 150 mg Extended-Release Capsules Under Fasting Conditions

10 mg Donepezil Hydrochloride Orally Disintegrating Tablets Under Fasting Conditions.

10 mg Donepezil Hydrochloride Orally Disintegrating Tablets Under Non-Fasting Conditions

Ranibizumab Short- and Log-term Effects on Retinal Function in wAMD

Response to Ranibizumab in Polypoidal Choroidal Vasculopathy (PCV)and SNPs

Clinical Investigation of Filter Improvement for New Filter to Ostomy Bags

Clinical Investigation for New Filter to Ostomy Bags

A Study Evaluating Dosing Regimens for Treatment With Intravitreal Ranibizumab Injections in Subjects With Macular Edema Following Retinal Vein Occlusion

Prospective, Randomized, Multicenter, Open Label, Phase II Study to Access Efficacy and Safety of Lucentis® Monotherapy Compared With Lucentis® Plus Panretinal Photocoagulation (PRP) and PRP in the Treatment of Patients With High Risk Proliferative Diabetic Retinopathy

Venlafaxine Hydrochloride 150 mg Extended-Release Capsules Under Fed Conditions

Venlafaxine Hydrochloride 150 mg Extended-Release Capsules Sprinkle Study

Intravitreal Ranibizumab in Exudative Age-related Macular Degeneration With Posterior Vitreomacular Adhesion

Ranibizumab 0.5mg and 2.0mg to Treat Diabetic Macular Edema in Patients With Poor Response to Bevacizumab

Ranibizumab "Treat and Extend" in Diabetic Macular Edma

Retinal Blood Flow in Response to an Intravitreal Injection of Ranibizumab for Central Retinal Vein Occlusion (CRVO)

ESBA1008 Safety, Tolerability and Effects in Wet Age-Related Macular Degeneration (AMD) Patients

Ranibizumab in Diabetic Vitrectomy. A Prospective, Randomised Controlled Trial of Ranibizumab Pre-treatment in Diabetic Vitrectomy - a Pilot Study

Safety and Efficacy Study in in Vitro Fertilisation (IVF) Patients

A Clinical Study in Current Medical Practice of the Efficacy and Safety of Ranibizumab 0.5mg in Diabetic Patients Presenting a Visual Impairment Due to Macular Edema

Observe the Effectiveness and Safety of Ranibizumab in Real Life Setting

Ranibizumab and the Risk of Arterial Thromboembolic Events

Ranibizumab Versus Low-fluence Photodynamic Therapy in the Treatment of Chronic Central Serous Chorioretinopathy

The Effect of Ranibizumab on Eye Lens Opacity in Cases With Age-Related Macular Degeneration

Avandamet Bioequivalence Study Brazil - Fed Administration

A Comparison of Solid and Soluble Forms of Cold and Influenza Remedies

Placebo Controlled Study for Characterisation of Immunological Effects and Safety of Active O2

High Dose Intravitreal Ranibizumab for Recalcitrant Radiation Retinopathy

Study to Compare Adhesiveness of Two Different Rotigotine Patch Formulations

Study to Evaluate the Safety and Effectiveness of IRay in Wet Age-related Macular Degeneration (AMD) Patients With Recurrent Leakage Secondary to Choroidal Neovascularisation (CNV)

Effect of the Consumption of a Fermented Milk Enriched With Plant Sterols

Norethindrone/Ethinyl Estradiol 0.4 mg/35 Mcg Chewable Tablets Under Fasting Conditions

Norethindrone/Ethinyl Estradiol 0.4 mg/35 Mcg Chewable Tablets Under Non-Fasted Conditions

2nd Pivotal Study rPhleum - Adults and Adolescents With Rhinoconjunctivitis +/-Controlled Asthma

Effects of Lactobacillus Delbruckii Lactis DN111244 Fermented Milk Consumption on Plasma Lipids Levels in Hypercholesterolaemic Adults

Aqueous Humor Level of Cytokines in Polypoidal Choroidal Vasculopathy and Change of Cytokines After Photodynamic Therapy

Retinal Ischemia in Central Retinal Vein Occlusion, and the Effects of Treatment With Intravitreal Ranibizumab

Nicotine Replacement Therapy in the Intensive Care Unit

Evaluation of Wet Age-Related Macular Degeneration (AMD) Genetic Profile Interactions With Ranibizumab Treatment Outcomes

Study to Evaluate the Effects of Ranibizumab (Lucentis) for Patients With Rubeosis and Neovascular Glaucoma

Comparative Bioavailability Study of Lisinopril Tablets, 10 mg

Efficacy and Safety of Ranibizumab in Japanese Patients With Retinal Vein Occlusion

Study of the Effect of a Fermented Dairy Product on Gastrointestinal Well Being in Adult Women

Efficacy and Safety of Ranibizumab Intravitreal Injections Versus Dexamethasone Intravitreal Implant in Patients With Branch Retinal Vein Occlusion (BRVO)

Efficacy and Safety of Ranibizumab Intravitreal Injections Versus Dexamethasone Intravitreal Implant in Patients With Central Retinal Vein Occlusion (CRVO)

Evaluation of AGN-150998 in Exudative Age-related Macular Degeneration (AMD)

Clinical Assessment Of Age-related Macular Degeneration Patients After Early Diagnosis and Treatment With Ranibizumab

Ranibizumab for the Management of Recurrent Nosebleeds in Patients With Hereditary Hemorrhagic Telangiectasia (HHT)

Efficacy and Safety Study of iSONEP With & Without Lucentis/Avastin/Eylea to Treat Wet AMD

Effect of Regular Consumption of Micronutrient Fortified Beverage on the Micronutrient Status of Indian Schoolchildren

A Comparative Study Between Lysine Clonixinate+Cyclobenzaprine and Caffeine+Carisoprodol+Sodium Diclofenac+Paracetamol

Effect of Consumption of Dairy Product on Upper Gastric Discomfort

Safety and Efficacy Study of Ozurdex® Compared to Lucentis® in Patients With Branch Retinal Vein Occlusion

Bevacizumab Versus Ranibizumab in Treatment of Macular Edema From Vein Occlusion

Amoxicillin Bioequivalence Study Brazil - Fast

Donepezil 10 mg Tablets Under Fasting Conditions

Donepezil 10 mg Tablets Under Fed Conditions

Topiramate Bioequivalence Study Brazil - Fast

An Extension Study to Evaluate Safety and Tolerability of Ranibizumab in Macular Edema Secondary to Retinal Vein Occlusion (Cohort 2)

Daytime Corneal Swelling During Wear of Narafilcon B Lenses

PF-04523655 Dose Escalation Study, and Evaluation of PF-04523655 With/Without Ranibizumab in Diabetic Macular Edema (DME)

Study to Assess the Effectiveness of Existing Anti vascUlar Endothelial Growth Factor (Anti VEGF) in Patients With Wet Age-related Macular Degeneration (wAMD) (AURA)

Hemodilution Versus Ranibizumab in Early-onset Central Retinal Vein Occlusion

A Healthy Female and Male Volunteers Aspirin Study

Wet AMD Recurrence Rate in Patients Stable on Three Month Ranibizumab Dosing

Study EvAluating Genotypes While Using Lucentis 2

Safety Study of 2.0mg Lucentis to Treat Polypoidal Choroidal Vasculopathy

Bioequivalence Study of Pediatric Formulations to Treat HIV Infection

Intravitreal Ranibizumab 0.5MG, or 1.0mg for RVO With Macular Edema Previously Receiving Bevacizumab

Ranibizumab in Residual Diabetic Macular Edema Following Previous Anti-VEGF Therapy

Analysis of Growth Factors in Patients Undergoing Lucentis or Avastin Injections for Diabetic Macular Edema and Exudative Macular Degeneration

Dosing Study of Ranibizumab for Diabetic Retinal and Macular Edema

Bevacizumab Versus Ranibizumab for the Treatment of Diabetic Macular Edema

Prompt Panretinal Photocoagulation Versus Ranibizumab+Deferred Panretinal Photocoagulation for Proliferative Diabetic Retinopathy

Safety and Efficacy Study of Dexamethasone Versus Ranibizumab in Patients With Diabetic Macular Edema

Safety and Efficacy Study of rAAV.sFlt-1 in Patients With Exudative Age-Related Macular Degeneration

Open Label to Study to Evaluate Effect of Alfilbercept on Patients With (FVPED) Fibrovascular Pigment Epithelial Detachment

IRay to Treat Polypoidal Choroidal Vasculopathy (PCV) Secondary to Age-Related Macular Degeneration (AMD

An Open-label Study to Evaluate the Clinical and Economic Benefits of I-Ray in Patients With Choroidal Neovascularization Secondary to Age-related Macular Degeneration

Effect of the Consumption of a Fermented Dairy Product Enriched With Plant Sterols

Long-term Effectiveness Study on Cholesterol-reducing Activity

Effect of the Consumption of a Fermented Dairy Drink on the Immune Function

Iray for Vascularized Pigment Epithelial Detachment (VPED) Secondary to Age Related Macular Degeneration

Clinical Equivalence Study of Mometasone Nasal Spray, 50 Mcg/Actuation

A Clinical Investigation of New Ostomy Appliances

Ranibizumab Intravitreal Injections in Patients With Visual Impairment Due to Macular Edema Secondary to Central Retinal Vein Occlusion

A 16 Week Evaluation of the Novartis Health Management Tool (HMT) in Age Related Macular Degeneration (AMD)

Study for Recalcitrant Age Related Macular Degeneration

Efficacy & Safety Trial of Intravitreal Injections Combined With PRP for CSME Secondary to Diabetes Mellitus (DAVE)

The LIMO Study, Lucentis for Treatment of Uveitic Patients With Refractory Cystoid Macular Oedema

A Randomized, Multi-center, Phase II Study of the Safety, Tolerability and Bioactivity of Repeated Intravitreal Injections of iCo-007 as Monotherapy or in Combination With Ranibizumab or Laser Photocoagulation in the Treatment of Diabetic Macular Edema (the iDEAL Study)

Bioequivalence Study of Levocetirizine Dihydrochloride Tablets 5 mg Under Fed Condition

Lucentis KAV Study

Pilot Study in the Cholesterol Absorption Reduction After Consumption of Low-fat, Drinkable Fermented Milk Enriched With Plant Sterols

Effects of Fermented Milk Product Enriched With Plant Sterols and Policosanols in Mild Hypercholesterolaemic Adults

Effect of the Consumption of a Fermented Milk Enriched With Plant Sterols (Italy)

A Comparative Study of Effects of Berry and Grain Products on Postprandial Glycemic Response in Healthy Subjects

Determining the Effect of Antibiotic Drop Prophylaxis on the Conjunctival Flora

Bioequivalence Study of Carvedilol Tablets USP 12.5 mg Under Fasting Condition

Bioequivalence Study of Ondansetron Tablets USP 8 mg Under Fasting Condition

Bioequivalence Study of Ondansetron Tablets USP 8 mg Under Fed Condition

Extension Study to Compare Long-term Efficacy and Safety of Ranibizumab Intravitreal Injections Versus Dexamethasone Intravitreal Implant in Patients With RVO

Ozurdex With Rescue Lucentis for Treating Macular Edema Secondary to Retinal Vein Occlusion

Multicenter 12 Months Clinical Study to Evaluate Efficacy and Safety of Ranibizumab Alone or in Combination With Laser Photocoagulation vs. Laser Photocoagulation Alone in Proliferative Diabetic Retinopathy (PRIDE)

Efficacy and Safety of Ranibizumab With or Without Laser in Comparison to Laser in Branch Retinal Vein Occlusion

Bioavailability Study With Oral Single Dose Administration of Ethinylestradiol and Dienogest

Effect of the Consumption of a Fermented Milk Enriched With Plant Sterols (Spain)

Bioequivalence Study of Allopurinol 300 mg Tablets USP Under Fasting Condition

Bioequivalence Study of Quetiapine Fumarate Tablets 25 mg Under Fasting Condition

Bioequivalence Study of Quetiapine Fumarate Tablets 25 mg Under Fed Condition

Delta-THC in Dementia

New Infant Formula Trial in Healthy Term Subjects on Growth, Body Composition, Tolerance and Safety

Ranibizumab and Bevacizumab for Diabetic Macular Edema

OsseoScrew Versus Fenestrated Pedicle Screws Augmented With Polymethylmethacrylate

Wet Macular Degeneration Study to Compare Ranibizumab or Bevacizumab to Aflibercept

Bioequivalence Study of Risperidone Tablet 1 mg Under Fed Condition

Bioequivalence Study of Lamotrigine Tablets 25 mg (2 x 25 mg Tablets) Under Fasting Condition

Bioequivalence Study of Lamotrigine Tablets 25 mg (2 x 25 mg Tablets) Under Fed Condition

Naloxone Nasal Spray Pharmacokinetic Study

Effect of Intravitreal Anti-VEGF on Retinal Vessels Diameter

Comparative Effectiveness Study of Intravitreal Aflibercept, Bevacizumab, and Ranibizumab for Diabetic Macular Edema

Study to Investigate the Safety and Efficacy of Ranibizumab in Patients With Choroidal Neovascularisation Due to Causes Other Than Age Related Macular Degeneration

Study in Healthy Volunteers to Establish the Bioequivalence of Two Different Manufacturers.

Comparing the Effectiveness and Costs of Bevacizumab to Ranibizumab in Patients With Diabetic Macular Edema (BRDME)

Comparing the Effectiveness and Costs of Bevacizumab to Ranibizumab in Patients With Retinal Vein Occlusions (BRVO)

Treatment of Diabetic Macular Edema With 0.5mg Intraocular Ranibizumab (Lucentis)

Anesthesia Preference for Intravitreal Injection: Topical or Subconjunctival

Evaluation of the Association Between Genetic Load and Response to Anti-VEGF Therapy in AMD Patients

Bioequivalence Study of Pantoprazole Sodium 40 mg Delayed Release Tablets Fasting Study

Bioequivalence Study of Pantoprazole Sodium 40 mg Delayed Release Tablets Fed Study

Bloodstream Absorption of Avastin and Lucentis After Injection Into the Eye

Triple Treatment for Detachment of Retinal Pigment Epithelium Secondary to Polypoidal Choroidal Vasculopathy

Evaluation of Changes in the Parameters of Optical Coherence Tomography After Intravitreal Injection of Lucentis

A Safety and Bioequivalence of a Mometasone Nasal Spray, 50 mcg/Actuation Compared With Nasonex® Nasal Spray 50 mcg/Actuation in the Relief of the Symptoms of Seasonal Allergic Rhinitis (SAR)

Pilot Study of X-82 in Patients With Wet AMD

Genetic Polymorphisms in Ranibizumab Treatment in Wet Age-Related Macular Degeneration (AMD)

Bioequivalence Study of 4 mg Glimepiride Tablet

Bioequivalence Study of Two Formulations of 500 mg Metformin Extended Release Tablet

Bioequivalence Study of Two Formulations of Perindopril 4 mg Tablet Under Fasting Condition

Study Comparing Imiquimod Cream, 3.75% to Zyclara® (Imiquimod) Cream, 3.75% in the Treatment of Actinic Keratosis

Therapeutic Equivalence Trial of Two Hormonal-IUDs in Patients With Heavy Menstrual Bleeding

Study to Evaluate Efficacy and Safety of Histrelin Subdermal Implant in Men With Advanced Prostate Cancer

Safety and Efficacy Study in Subjects With Seborrheic Dermatitis

Widefield Angiography Guided Targeted-retinal Photocoagulation Combined With Anti VEgf Intravitreal Injections for the Treatment of Ischemic Central Retinal Vein Occlusion, Hemi Retinal Vein Occlusion, and Branch Retinal Vein Occlusion

Rosuvastatin Calcium Bioequivalence Study - Fast

Neovascular Age-related Macular Degeneration

Two Way Cross Over BE Fasting Pilot Study of Ropinirole Hydrochloride CR 2mg Tablets

Bioequivalence Study of Ropinirole Hydrochloride CR 2mg Tablets of Lupin Limited, India, With REQUIP XL of GlaxoSmithKline Research Triangle Park, in Healthy, Adult, Male, Subjects Under Fed Conditions

A Crossover Bioequivalence Study of Intravenously Administered ATI0918 and DOXIL/CAELYX in Patients With Ovarian Cancer

Bioequivalence Study of Ropinirole Hydrochloride CR 2mg Tablets of Lupin Limited, India, With REQUIP XL of GlaxoSmithKline Research Triangle Park, in Healthy, Adult, Male, Subjects Under Fasting Conditions

Bioequivalence Study of Indomethacin Extended-Release Capsules 75 mg Under Fed Condition

Bioequivalence Study of Risperidone Tablet 1 mg Under Fasting Condition

Bioequivalence Study of Lisinopril Tablets 40 mg Under Fasting Condition

Bioequivalence Study of Lisinopril Tablets 40 mg Under Fed Condition

Bioequivalence Study of Etodolac Tablet USP 500 mg Under Fasting Condition

Bioequivalence Study of Etodolac Tablet USP 500 mg Under Fed Condition

Bioequivalence Study of 300 mg Gabapentin

Safety and Tolerability of Namisol in the Elderly

Bioequivalence Study of Bisoprolol Fumarate Tablet 10 mg Under Fasting Condition

Study Comparing Adapalene and Benzoyl Peroxide Gel 0.1%/2.5% to Epiduo® and Both to a Placebo Control in the Treatment of Acne Vulgaris

A Multicenter Study of Pseudoephedrine for the Temporary Relief of Nasal Congestion in Children With the Common Cold

Bioequivalence Study of Bisoprolol Fumarate Tablet 10 mg Under Fed Condition

Bioequivalence Trial of Alprazolam 0.5 mg Tablets

Bioequivalence Trial of Alprazolam 2 mg Tablets

Bioequivalence Study of Escitalopram Tablets 10 mg

Bioequivalence Study of Nimesulide 100 mg Tablets

Intravitreal Ranibizumab Combined With Panretinal Photocoagulation in Patients With Proliferative Diabetic Retinopathy

Bioequivalence Study of Etodolac Capsules USP 300 mg Under Fasting Condition

Treat & Extend Treatment With 0.5mg Ranibizumab vs Monthly Treatment With 0.5mg Ranibizumab

Bioequivalence Study of Etodolac Capsules USP 300 mg Under Fed Condition

Assessment of the Relative Increase in Bioavailability of (Non-) Nutrients From a Mixed Salad by Adding Fat Containing Dressing

Bioequivalence Minocycline Bioequivalence

Evaluation of Safety and Efficacy of rhNGF in Patients With Stage 2 and 3 Neurotrophic Keratitis.

Comparison of Changes of Inflammatory Proteins in Aqueous Humour of Subjects Treated With Avastin vs Lucentis

Pivotal Bioequivalence Study of Exemestane 25 mg Tablets Under Fasting Conditions in Healthy Subjects

Bioequivalence Study of Cephalexin Suspension 125

Bioequivalence Study of Cephalexin Suspension 250

Bioequivalence Study of Cephalexin Tablets 1g

Study Comparing Clindamycin Phosphate and Benzoyl Peroxide Gel to Acanya® Gel and Both to a Vehicle Control in the Treatment of Acne Vulgaris

A Test of Different Kinds of Bandages on Healing of Wounds

Evaluation of Changes in Visual Acuity in Patients With Diabetic Macular Edema (DME) Starting Treatment With an Approved Anti-VEGF Therapy

Bioequivalence Study for Terbinafine 250 mg

Bioequivalence Study of an Amoxicillin-Clavulanic

Efficacy and Safety of Ranibizumab 0.5 mg Administered as Two Alternative Dosing Regimens in Chinese Patients With nAMD (Age Related Macular Degeneration)

Study to Evaluate the Safety and Bioequivalence of Estradiol Vaginal Inserts, 10 mcg and Vagifem® 10 mcg and Compare to Placebo